Seres Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Seres Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2016 to Q3 2024.
  • Seres Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 152 %, a 40% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 152 -101 -40% Sep 30, 2024
Q2 2024 183 -78.8 -30.1% Jun 30, 2024
Q1 2024 228 -12.2 -5.09% Mar 31, 2024
Q4 2023 237 -33.2 -12.3% Dec 31, 2023
Q3 2023 253 -51.9 -17% Sep 30, 2023
Q2 2023 262 -64.1 -19.7% Jun 30, 2023
Q1 2023 240 -125 -34.3% Mar 31, 2023
Q4 2022 270 -135 -33.4% Dec 31, 2022
Q3 2022 305 -145 -32.3% Sep 30, 2022
Q2 2022 326 -211 -39.3% Jun 30, 2022
Q1 2022 365 -124 -25.4% Mar 31, 2022
Q4 2021 406 +1.14 +0.28% Dec 31, 2021
Q3 2021 451 +139 +44.6% Sep 30, 2021
Q2 2021 537 +343 +176% Jun 30, 2021
Q1 2021 489 +273 +126% Mar 31, 2021
Q4 2020 404 +192 +90.7% Dec 31, 2020
Q3 2020 312 +99.2 +46.7% Sep 30, 2020
Q2 2020 194 -16.3 -7.74% Jun 30, 2020
Q1 2020 216 +2.05 +0.96% Mar 31, 2020
Q4 2019 212 -49.5 -18.9% Dec 31, 2019
Q3 2019 213 -112 -34.5% Sep 30, 2019
Q2 2019 211 -218 -50.9% Jun 30, 2019
Q1 2019 214 -317 -59.7% Mar 31, 2019
Q4 2018 262 -366 -58.3% Dec 31, 2018
Q3 2018 324 -349 -51.8% Sep 30, 2018
Q2 2018 429 -244 -36.3% Jun 30, 2018
Q1 2018 531 -167 -24% Mar 31, 2018
Q4 2017 627 -186 -22.8% Dec 31, 2017
Q3 2017 673 -317 -32% Sep 30, 2017
Q2 2017 673 -732 -52.1% Jun 30, 2017
Q1 2017 698 -1.1K -61.2% Mar 31, 2017
Q4 2016 813 Dec 31, 2016
Q3 2016 990 Sep 30, 2016
Q2 2016 1.4K Jun 30, 2016
Q1 2016 1.8K Mar 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.